Zostavax Vaccine to Prevent Shingles - FDA Approval

Links shared publicly online about this topic.

  • 413
    total visits

Zostavax Vaccine to Prevent Shingles - FDA Approval

disabled-world.com

FDA approves Zostavax a live attenuated virus vaccine for the prevention of shingles in individuals 50 to 59 years of age

View full resource at disabled-world.com

Tags: Vaccination, Shingles, FDA, Vaccine

  • Share

Most Recently Shared on March 31, 2011 at 12:54 pm By:

Health_SS Susan S

Zostavax Vaccine to Prevent Shingles - FDA Approval: FDA Approves Zostavax Vaccine to Prevent… http://goo.gl/fb/ttfE6

1 year ago...

Also Shared By:

Disabled World Disabled World

RxEconsult, LLC - Zostavax (Zoster Vaccine Live) for preventing shingles (herpes zoster)

rxeconsult.com — “RxEconsult, LLC - Zostavax (Zoster Vaccine Live) for preventing shingles (herpes zoster)View full resource at rxeconsult.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 12:20 pm By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD

Zostavax Gains Expanded Indication - ONA

oncologynurseadvisor.com — “Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50--59 years of age.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 3:07 pm By:

Zostavax Gains Expanded Indication - MPR

empr.com — “Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50--59 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 2:59 pm By:

eMPR MPR Medical Publisher

MPR News: Zostavax Gains Expanded Indication: Merck announced that Zostavax (varicella zoster vaccine, live, att... http://bit.ly/iaTKS9

1 year ago...

Shingles Vaccine (Zostavax, Zoster Vaccine Live) Side Effects, Complications, Warnings and Precautions by MedicineNet.com

medicinenet.com — “The shingles vaccine (Zostavax) is given to people over 60 years of age to prevent shingles. Read about side effects, contraindications, dosage and adverse reactions.View full resource at medicinenet.com

  • View Related
  • Share

Most Recently Shared on November 10, 2010 at 5:51 pm By:

Advertisement